These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 9394873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD, Holman SL, Sayler ME, Potvin JH.
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [Abstract] [Full Text] [Related]

  • 4. Lack of association between fluoxetine and suicidality in bulimia nervosa.
    Wheadon DE, Rampey AH, Thompson VL, Potvin JH, Masica DN, Beasley CM.
    J Clin Psychiatry; 1992 Jul; 53(7):235-41. PubMed ID: 1639742
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF, Lane RM, Zhu R, Ying Z.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM, Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME.
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [Abstract] [Full Text] [Related]

  • 11. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C, Ceccherininelli A, Rossi A, Maggini C.
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 14. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
    Goldstein DJ, Rampey AH, Potvin JH, Masica DN, Beasley CM.
    J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression.
    Tollefson GD, Rampey AH, Beasley CM, Enas GG, Potvin JH.
    J Clin Psychopharmacol; 1994 Jun; 14(3):163-9. PubMed ID: 8027412
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.